Literature DB >> 36056987

Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood.

Yasushi Ishida1, Kiyoko Kamibeppu2, Atsushi Sato3, Masami Inoue4, Akira Hayakawa5, Masaaki Shiobara6, Hiromasa Yabe7, Kazutoshi Koike8, Soichi Adachi9, Takuya Yamashita10, Yoshinobu Kanda11, Shinichiro Okamoto12, Yoshiko Atsuta13,14.   

Abstract

The purpose of this study was to investigate Karnofsky performance status (KPS) scores and visual analogue scale (VAS) scores to explain which domains in the standardized self-reported quality of life (QOL) are instrumental for long-term hematopoietic stem cell transplantation (HSCT) survivors. We conducted a nationwide cross-sectional questionnaire study on 221 survivors with allogeneic-HSCT in 28 pediatric centers. Patient-reported QOL was assessed at a single time point using the 36-item Short-Form Survey (SF-36), the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT), and VAS scores. KPS scores were significantly correlated with both physical and role component summary scores of the SF-36, while the VAS provided by the patient (VASpt) was significantly correlated with the mental component summary score of the SF-36 and many subscales of the FACT-BMT. The VAS provided by the participants' attending physician (VASdoc) was correlated well with KPS scores. A VASpt score more than 40% lower than KPS scores suggested mental health problems. In conclusion, KPS scores might be considered as an indicator for physical and role/social components and VASpt score as an indicator for mental components and HSCT-specific QOL.
© 2022. Japanese Society of Hematology.

Entities:  

Keywords:  Allogeneic hematopoietic stem cells transplantation; Karnofsky scores; QOL; Survivors; VAS scores

Year:  2022        PMID: 36056987     DOI: 10.1007/s12185-022-03426-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  20 in total

Review 1.  Health-related quality of life of hematopoietic stem cell transplant childhood survivors: state of the science.

Authors:  Elizabeth M Tanzi
Journal:  J Pediatr Oncol Nurs       Date:  2011-06-02       Impact factor: 1.636

2.  Validation testing of a three-component model of Short Form-36 scores.

Authors:  Yoshimi Suzukamo; Shunichi Fukuhara; Joseph Green; Mark Kosinski; Barbara Gandek; John E Ware
Journal:  J Clin Epidemiol       Date:  2011-03       Impact factor: 6.437

3.  Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data).

Authors:  Yoshiko Atsuta
Journal:  Int J Hematol       Date:  2015-11-07       Impact factor: 2.490

4.  Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan.

Authors:  S Fukuhara; S Bito; J Green; A Hsiao; K Kurokawa
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale.

Authors:  R P McQuellon; G B Russell; D F Cella; B L Craven; M Brady; A Bonomi; D D Hurd
Journal:  Bone Marrow Transplant       Date:  1997-02       Impact factor: 5.483

6.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

7.  Physical and psychosocial functioning of 117 survivors of bone marrow transplantation.

Authors:  J M Prieto; R Saez; E Carreras; J Atala; J Sierra; M Rovira; M Batlle; J Blanch; R Escobar; E Vieta; E Gomez; C Rozman; E Cirera
Journal:  Bone Marrow Transplant       Date:  1996-06       Impact factor: 5.483

8.  Health-related quality of life (HRQoL): the impact of medical and demographic variables upon pediatric recipients of hematopoietic stem cell transplantation.

Authors:  Lisa Brice; Rebecca Weiss; Ying Wei; Prakash Satwani; Monica Bhatia; Diane George; James Garvin; Erin Morris; Lauren Harrison; Mitchell S Cairo; Stephen A Sands
Journal:  Pediatr Blood Cancer       Date:  2011-04-21       Impact factor: 3.167

Review 9.  Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.

Authors:  Eric J Chow; Lynnette Anderson; K Scott Baker; Smita Bhatia; Gregory M T Guilcher; Jennifer T Huang; Wendy Pelletier; Joanna L Perkins; Linda S Rivard; Tal Schechter; Ami J Shah; Karla D Wilson; Kenneth Wong; Satkiran S Grewal; Saro H Armenian; Lillian R Meacham; Daniel A Mulrooney; Sharon M Castellino
Journal:  Biol Blood Marrow Transplant       Date:  2016-01-21       Impact factor: 5.742

10.  The quality of life of adult survivors of childhood hematopoietic cell transplant.

Authors:  J E Sanders; P A Hoffmeister; B E Storer; F R Appelbaum; R F Storb; K L Syrjala
Journal:  Bone Marrow Transplant       Date:  2009-08-31       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.